• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Evolus (EOLS)

Common Shares
Sell: $4.56|Buy: $4.65|Change: 0.19 (4.28%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Address

520 Newport Center Drive
Suite 1200
Newport Beach
CA
USA
92660

Telephone

+1 949 284-4555

Website

https://www.evolus.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Evolus Inc Fourth Quarter Earnings Conference Call for 20262027-03-03T16:30:00
Evolus Inc Fourth Quarter Earnings Results for 20262027-03-03T00:00:00
Evolus Inc Annual Report for 20262027-03-03T00:00:00
Evolus Inc Third Quarter Earnings Conference Call for 20262026-11-05T16:30:00
Evolus Inc Third Quarter Earnings Results for 20262026-11-05T00:00:00
Evolus Inc Second Quarter Earnings Conference Call for 20262026-08-05T16:30:00
Evolus Inc Second Quarter Earnings Results for 20262026-08-05T00:00:00
Evolus Inc Annual General Meeting for 20262026-06-05T08:00:00
Evolus Inc First Quarter Earnings Conference Call for 20262026-05-04T16:30:00
Evolus Inc First Quarter Earnings Result for 20262026-05-04T00:00:00
Needham Virtual Healthcare Conference2026-04-14T15:45:00

Previous key dates

NameKey Date
Needham Virtual Healthcare Conference2026-04-14T15:45:00
Leerink Partners Global Healthcare Conference2026-03-11T11:20:00
Evolus Inc Fourth Quarter Earnings Conference Call for 20252026-03-03T16:30:00
Evolus Inc Fourth Quarter Earnings Result for 20252026-03-03T00:00:00
Evolus Inc Annual Report for 20252026-03-03T00:00:00
Evolus to Participate in 2025 Stifel Healthcare Conference2025-11-11T11:20:00
Evolus Inc Third Quarter Earnings Conference Call for 20252025-11-05T16:30:00
Evolus Inc Third Quarter Earnings Result for 20252025-11-05T00:00:00
Evolus Inc Second Quarter Earnings Conference Call for 20252025-08-05T16:30:00
Evolus Inc Second Quarter Earnings Result for 20252025-08-05T00:00:00
Evolus Inc Annual General Meeting for 20252025-06-05T08:00:00
Evolus Inc First Quarter Earnings Conference Call for 20252025-05-07T16:30:00
Evolus Inc First Quarter Earnings Result for 20252025-05-07T00:00:00
The Needham 24th Annual Virtual Healthcare Conference2025-04-08T12:45:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.